Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations-Reference-Cited by-同舟云学术

Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations

Published:2021-10 Issue:1 Volume:37 Page:106-118
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Caminiti Silvia Paola¹²³^ORCID,Carli Giulia¹²,Avenali Micol⁴⁵,Blandini Fabio⁴⁵^ORCID,Perani Daniela¹²³

Affiliation:

1. School of Psychology, Vita‐Salute San Raffaele University Milan Italy

2. In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience IRCCS San Raffaele Scientific Institute Milan Italy

3. Nuclear Medicine Unit San Raffaele Hospital Milan Italy

4. IRCCS Mondino Foundation Pavia Italy

5. Department of Brain and Behavioural Sciences University of Pavia Pavia Italy

Funder

AbbVie

Allergan

Avid Radiopharmaceuticals

Biogen

Bristol-Myers Squibb

Celgene

Denali Commission

GE Healthcare

Genentech Foundation

GlaxoSmithKline

Lilly Deutschland

Lundbeckfonden

Merck KGaA

Michael J. Fox Foundation for Parkinson's Research

Pfizer

Roche

Sanofi Genzyme

Servier

Takeda Pharmaceuticals North America

Teva Pharmaceutical Industries

UCB

Verily Life Sciences

Voyager Therapeutics

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28818

Reference53 articles.

1. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

2. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

3. GBA1-associated parkinsonism: new insights and therapeutic opportunities

5. THE NEUROLOGY OF OLD AGE.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease;Translational Neurodegeneration;2024-09-12

2. Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriers;npj Parkinson's Disease;2024-06-29

3. Combined detrimental effect of male sex and GBA1 variants on cognitive decline in Parkinson’s Disease;2024-04-03

4. GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy;Journal of Movement Disorders;2023-09-30

5. Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease;Neurobiology of Disease;2023-09